Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia
Authors:
- Amir T. FathiAFAmir T. Fathi
- Haesook T. KimHKHaesook T. Kim
- Robert J. SoifferRSRobert J. Soiffer
- Mark J. LevisMLMark J. Levis
- Shuli LiSLShuli Li
- Annette S. KimAKAnnette S. Kim
- Zachariah DeFilippZDZachariah DeFilipp
- Areej El-JawahriAEAreej El-Jawahri
- Steve L. McAfeeSMSteve L. McAfee
- Andrew M. BrunnerABAndrew M. Brunner
- Philip C. AmreinPAPhilip C. Amrein
- Alice S. MimsAMAlice S. Mims
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)